These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15221581)

  • 21. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The attractiveness of opposites: agonists and antagonists.
    O'Brien T
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):67-9. PubMed ID: 25643224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Opioid-Induced Constipation in Hospice Patients.
    Sera L; McPherson ML
    Am J Hosp Palliat Care; 2018 Feb; 35(2):330-335. PubMed ID: 28423917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
    Reimer K; Hopp M; Zenz M; Maier C; Holzer P; Mikus G; Bosse B; Smith K; Buschmann-Kramm C; Leyendecker P
    Pharmacology; 2009; 83(1):10-7. PubMed ID: 18957874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylnaltrexone for the treatment of opioid-induced constipation.
    Bader S; Dürk T; Becker G
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):13-26. PubMed ID: 23265145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
    Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lubiprostone for the treatment of opioid-induced bowel dysfunction.
    Wong BS; Camilleri M
    Expert Opin Pharmacother; 2011 Apr; 12(6):983-90. PubMed ID: 21385112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral opioid antagonists: a therapeutic advance for optimizing opioid gastrointestinal tolerability.
    Fakata KL; Cole BE
    J Fam Pract; 2007 Jun; 56(6 Suppl Peripheral):S3-12. PubMed ID: 17543252
    [No Abstract]   [Full Text] [Related]  

  • 30. Analgesia issues in palliative care: bone pain, controlled release opioids, managing opioid-induced constipation and nifedipine as an analgesic.
    Fine PG
    J Pain Palliat Care Pharmacother; 2002; 16(1):93-7. PubMed ID: 14650452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Jansen JP; Lorch D; Langan J; Lasko B; Hermanns K; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):185-93. PubMed ID: 21292169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylnaltrexone for opioid-induced constipation in a pediatric oncology patient.
    Kissling KT; Mohassel LR; Heintz J
    J Pain Symptom Manage; 2012 Jul; 44(1):e1-3. PubMed ID: 22770490
    [No Abstract]   [Full Text] [Related]  

  • 34. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
    Holzer P
    Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of opioid-induced constipation.
    Prichard D; Norton C; Bharucha AE
    Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palliative care and pain: new strategies for managing opioid bowel dysfunction.
    Thomas JR; Cooney GA; Slatkin NE
    J Palliat Med; 2008 Sep; 11 Suppl 1():S1-19; quiz S21-2. PubMed ID: 18800914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases.
    Daeninck PJ; Bruera E
    J Pain Symptom Manage; 1999 Oct; 18(4):303-9. PubMed ID: 10534971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic treatment of constipation in cancer patients.
    Avila JG
    Cancer Control; 2004; 11(3 Suppl):10-8. PubMed ID: 15153835
    [No Abstract]   [Full Text] [Related]  

  • 40. [Opioid-Induced Constipation in Patients with Cancer Pain].
    Aruga E
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.